irblog.prnewswire.com

Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

UK-based Albumedix Ltd. is a leader in the field of recombinant albumin-based solutions and a highly innovative and profitable company Recombinant human albumin is a critical component in the ...
Finanznachrichten

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

NOTTINGHAM, England, March 14, 2023 /PRNewswire/ --Albumedix Ltd ('Albumedix'), Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc ('Heartseed'), Tokyo, ...
PR Newswire

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Recombumin, an animal and human origin free recombinant albumin, is an excipient in the final formulation of Heartseed's HS-001 treatment. In February 2023, Heartseed announced successful dosing of HS ...